SPI.L

Spire Healthcare Group Plc
Spire Healthcare Grp - Transaction in Own Shares
3rd December 2024, 07:15
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5008O
Spire Healthcare Group PLC
03 December 2024
 

3 December 2024

Spire Healthcare Group plc

Transaction in own shares

Spire Healthcare Group plc (the "Company") announces that, in accordance with the terms of its share buyback programme announced on 31 October 2024 (the "Share Buyback Programme") and the authority granted by its shareholders at the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased the following number of its ordinary shares of 1 pence each ("Shares") on the London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):

Date of purchase:

2 December 2024

Number of Shares purchased:

17,444

Highest price paid per Share (GBp):

226.50

Lowest price paid per Share (GBp):

225.00

Volume weighted average price paid per Share (GBp):

225.7434

Broker:

Deutsche Numis

Trading venue:

London Stock Exchange

            The purchased Shares will be cancelled.

Following the purchase of these Shares, the remaining number of Shares in issue will be 403,097,028. The Company does not hold any Shares in treasury. Therefore, the total number of voting rights in the Company is 403,097,028. This figure may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Deutsche Numis as part of the Share Buyback Programme:

 

Number of ordinary shares purchased

Transaction price
(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

2511

225.50

 08:29:53

00072652403TRLO0

XLON

2420

225.00

 08:29:55

00072652409TRLO0

XLON

230

225.00

 08:33:49

00072652512TRLO0

XLON

500

225.50

 08:48:39

00072652886TRLO0

XLON

552

225.50

 08:49:02

00072652916TRLO0

XLON

300

225.50

 08:49:02

00072652915TRLO0

XLON

185

225.50

 08:59:29

00072653225TRLO0

XLON

400

225.50

 08:59:29

00072653224TRLO0

XLON

200

225.50

 08:59:29

00072653223TRLO0

XLON

100

225.50

 09:04:29

00072653470TRLO0

XLON

300

225.50

 09:05:14

00072653499TRLO0

XLON

247

225.50

 09:07:12

00072653590TRLO0

XLON

140

225.50

 09:11:02

00072653696TRLO0

XLON

420

226.50

 09:31:08

00072654350TRLO0

XLON

163

226.50

 09:31:08

00072654353TRLO0

XLON

136

226.50

 09:31:08

00072654352TRLO0

XLON

735

226.50

 09:31:08

00072654351TRLO0

XLON

67

226.50

 09:31:08

00072654356TRLO0

XLON

94

226.50

 09:31:08

00072654355TRLO0

XLON

167

226.50

 09:31:08

00072654354TRLO0

XLON

1155

226.00

 09:31:48

00072654385TRLO0

XLON

1221

226.00

 09:31:48

00072654384TRLO0

XLON

2315

226.00

 10:00:23

00072655167TRLO0

XLON

245

226.00

 10:00:23

00072655166TRLO0

XLON

100

226.00

 11:00:59

00072656835TRLO0

XLON

368

226.00

 11:00:59

00072656834TRLO0

XLON

29

226.00

 11:00:59

00072656833TRLO0

XLON

82

226.00

 11:14:00

00072657227TRLO0

XLON

100

226.00

 11:14:00

00072657226TRLO0

XLON

200

226.00

 11:14:00

00072657225TRLO0

XLON

200

226.00

 11:25:00

00072657489TRLO0

XLON

100

226.00

 11:25:00

00072657488TRLO0

XLON

308

226.00

 11:35:25

00072657718TRLO0

XLON

416

226.00

 11:35:25

00072657719TRLO0

XLON

440

226.00

 11:42:00

00072657834TRLO0

XLON

297

226.00

 11:42:00

00072657833TRLO0

XLON

1

226.00

 11:42:00

00072657832TRLO0

XLON

 

This announcement will also be available on the Company's website at:

https://investors.spirehealthcare.com/news/regulatory-news/

 

Enquiries:

 

Spire Healthcare

Harbant Samra, CFO                                                     +44 (0)7881 672 365

 

Instinctif Partners

Julian Walker                                                                 +44 (0)7825 189 696

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

 

About Spire Healthcare

 

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVLLFBZLLLFBQ]]>
TwitterFacebookLinkedIn